Rochester, Minn.-based Mayo Clinic has deployed a new AI infrastructure as part of its broader push to integrate advanced technologies into clinical care.
The health system partnered with Nvidia to launch a DGX SuperPOD powered by DGX B200 systems, an AI computing platform designed to support the development of foundation models used in areas such as digital pathology, drug discovery and precision medicine, according to a July 28 news release.
Mayo officials said the new computing capabilities align with its Bold. Forward. strategy and will support the organization’s work in generative AI — including early disease detection, model training and workflow automation.
The Nvidia Blackwell-powered SuperPOD is optimized for processing high-resolution imaging and is expected to significantly reduce the time required to analyze pathology slides. Tasks that previously took four weeks can now be completed in one, according to Mayo Clinic.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
